ADMA Biologics Inc (NAS:ADMA)
$ 17.67 0.26 (1.49%) Market Cap: 4.12 Bil Enterprise Value: 4.14 Bil PE Ratio: 62.18 PB Ratio: 17.75 GF Score: 68/100

ADMA Biologics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 30, 2021 / 01:20PM GMT
Release Date Price: $1.13
Kristen Kluska
Cantor Fitzgerald - Analyst

Hello, everyone. I am Kristen Kluska, one of the biotechnology analysts at Cantor. It's my pleasure to host ADMA Biologics today. And joining me on this fireside chat are Adam Grossman, the Founder, Director, President and CEO; and Brian Lenz, the Executive Vice President and CFO. Thank you for joining us and for being at our conference today.

Adam Grossman
ADMA Biologics, Inc. - Founder, Director, President & CEO

Thank you so much, Kristen. We appreciate the opportunity to speak with you, and thank you to the Cantor team for the invitation.

Questions & Answers

Kristen Kluska
Cantor Fitzgerald - Analyst

Great, thanks. So for those who are relatively new to this story, could you please describe the benefits of plasma-derived therapies and your three commercial products?

Adam Grossman
ADMA Biologics, Inc. - Founder, Director, President & CEO

Sure. Happy to do so. So yes, we are an end-to-end vertically

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot